Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Computer Assisted Tomography
85%
Neoplasm
84%
Positron Emission Tomography
83%
Positron Emission Tomography
77%
Systematic Review
76%
Magnetic Resonance Imaging
62%
Diagnosis
62%
Fluorodeoxyglucose F 18
49%
Infection
49%
Meta-Analysis
49%
Breast Cancer
42%
Radioactive Tracer
41%
Malignant Neoplasm
40%
Disease
38%
Brain Ischemia
35%
Isotopes of Calcium
33%
Radiation Therapy
33%
Nuclear Medicine
32%
Apoplexy
31%
Head and Neck Cancer
30%
Fluorine-18
30%
Biological Marker
29%
Quality of Life
28%
Low Drug Dose
27%
Surgery
26%
Molecular Imaging
26%
Odds Ratio
25%
Lung Cancer Screening
23%
Radiology
23%
Coronary Artery
23%
Kidney Graft
22%
Kidney Transplantation
21%
Cohort Analysis
20%
Injury
19%
Lung Cancer
19%
Recurrent Disease
19%
Scintigraphy
19%
Symptom
19%
Cardiac Magnetic Resonance Imaging
18%
Lung Nodule
18%
Computed Tomography Angiography
18%
Radiomics
18%
Randomized Controlled Trial
18%
Diagnostic Accuracy
18%
Cardiovascular System
18%
Prostate Cancer
17%
Coronary Artery Disease
17%
Health Care Cost
17%
Overall Survival
16%
Pediatrics
16%
Diagnostic Performance
16%
Single-Photon Emission Computed Tomography
16%
Imaging Technique
15%
Implant
15%
Clinician
15%
Prevalence
15%
Heart Muscle Perfusion
14%
Cardiovascular Disease
14%
Postoperative Complication
13%
Hazard Ratio
13%
BRCA1
13%
Reproducibility
13%
Biopsy
13%
Neck
13%
Surgeon
12%
Ex Vivo
12%
Ovarian Cancer
11%
Leukocyte
11%
Chemoradiotherapy
11%
Logistic Regression Analysis
11%
Prosthetics
11%
Cancer
11%
Diagnostic Imaging
11%
Population
11%
Vasculitis
11%
Cost-Effectiveness Analysis
11%
Image Quality
10%
Oncology
10%
Modified Rankin Scale
10%
Screening
10%
Prospective Cohort Study
10%
Arm
10%
Retrospective Study
10%
Diffusion MRI
10%
Metastatic Carcinoma
10%
Sensitivity and Specificity
10%
Chronic Obstructive Pulmonary Disease
10%
Frailty
10%
Zirconium 89
10%
COVID-19
9%
Carbon 11
9%
Artery
9%
Maturity Onset Diabetes of the Young
9%
Breast Cancer Screening
9%
Cross Sectional Study
9%
Emphysema
9%
Fluorodeoxyglucose
9%
Proportional Hazards Model
9%
Pelvis
9%
Keyphrases
Positron Emission Tomography
25%
Positron Emission Tomography-computed Tomography (PET-CT)
22%
Meta-analysis
19%
Netherlands
17%
Computed Tomography
16%
Confidence Interval
15%
Head-and-neck Cancer
15%
Endovascular Treatment
13%
Systematic Meta-analysis
13%
Cancer Patients
12%
Kidney Transplant Recipients
11%
Acute Ischemic Stroke
11%
Tumor
11%
Radiotherapy
10%
Magnetic Resonance Imaging
10%
Dutch
10%
Kidney Transplantation
10%
18F-fluorodeoxyglucose (18F-FDG)
10%
F-18
10%
Nuclear Medicine
9%
18F-FDG PET-CT
9%
Lung Cancer Screening
9%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
9%
Molecular Imaging
8%
Functional Outcome
8%
Single-photon Emission Computed Tomography (SPECT)
8%
Lung Cancer
8%
Quality of Life
8%
Molecular Motor
8%
Breast Cancer
7%
MR CLEAN Registry
7%
PET Imaging
7%
Diagnostic Accuracy
7%
Cardiovascular Disease
7%
Nuclear Imaging
7%
Overall Survival
7%
Cost-effectiveness
7%
Odds Ratio
6%
Whole-body
6%
Periprosthetic Joint Infection
6%
Coronary Artery Calcium Score
6%
Coronary Artery Disease
6%
European Society
6%
Computational Imaging
6%
Multicenter Cohort Study
6%
Postoperative Complications
6%
P-glycoprotein Activity
6%
European Associations
6%
Fluorodeoxyglucose
5%
C-11
5%
Fracture-related Infection
5%
Clinical Outcomes
5%
Neuroinflammation
5%
Hazard Ratio
5%
High Risk
5%
Blood-brain Barrier
5%
Health-related Quality of Life
5%
P-glycoprotein (P-gp)
5%
Frailty
5%
Radiopharmaceuticals
5%
Diagnostic Performance
5%
Standardized Uptake Value
5%
Radiologists
5%
Biobank
5%
SNMMI
5%
Transplantation
5%